Galmed Pharmaceuticals Ltd (GPH) Stock Price & News

All values in USD	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	1.06M	1.09M	2.10M	1.36M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.05M	1.01M	946.00K	684.00K
Operating expense	2.11M	2.10M	3.04M	2.04M
Total operating expenses	2.11M	2.10M	3.04M	2.04M
Operating income	-2.11M	-2.10M	-3.04M	-2.04M
Other non operating income	-	-	-16.00K	-
EBT including unusual items	-2.50M	-1.89M	-4.82M	-1.91M
EBT excluding unusual items	-1.97M	-1.89M	-2.79M	-1.91M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-2.50M	-1.89M	-4.82M	-1.91M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	140.00K	203.00K	420.00K	134.00K
Interest expense	-	-	-79.00K	-
Net interest expenses	140.00K	203.00K	341.00K	134.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-2.09M	-2.07M	-3.02M	-
Gain or loss from assets sale	-	-	-	-

Finance